rs147258453
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBS1BS2
The NM_005251.3(FOXC2):c.1331A>G(p.Gln444Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00201 in 1,612,680 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 4 hom. )
Consequence
FOXC2
NM_005251.3 missense
NM_005251.3 missense
Scores
2
9
8
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
FOXC2 (HGNC:3801): (forkhead box C2) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10794449).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00128 (194/152124) while in subpopulation NFE AF = 0.00235 (160/67968). AF 95% confidence interval is 0.00206. There are 0 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 194 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 194AN: 152008Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
194
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00115 AC: 284AN: 246900 AF XY: 0.00109 show subpopulations
GnomAD2 exomes
AF:
AC:
284
AN:
246900
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00208 AC: 3045AN: 1460556Hom.: 4 Cov.: 32 AF XY: 0.00198 AC XY: 1437AN XY: 726566 show subpopulations
GnomAD4 exome
AF:
AC:
3045
AN:
1460556
Hom.:
Cov.:
32
AF XY:
AC XY:
1437
AN XY:
726566
Gnomad4 AFR exome
AF:
AC:
14
AN:
33480
Gnomad4 AMR exome
AF:
AC:
60
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
2
AN:
26136
Gnomad4 EAS exome
AF:
AC:
1
AN:
39696
Gnomad4 SAS exome
AF:
AC:
23
AN:
86258
Gnomad4 FIN exome
AF:
AC:
4
AN:
52130
Gnomad4 NFE exome
AF:
AC:
2832
AN:
1111980
Gnomad4 Remaining exome
AF:
AC:
107
AN:
60384
Heterozygous variant carriers
0
175
350
525
700
875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
116
232
348
464
580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00128 AC: 194AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.00110 AC XY: 82AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
194
AN:
152124
Hom.:
Cov.:
33
AF XY:
AC XY:
82
AN XY:
74396
Gnomad4 AFR
AF:
AC:
0.000312997
AN:
0.000312997
Gnomad4 AMR
AF:
AC:
0.00104616
AN:
0.00104616
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0.000193874
AN:
0.000193874
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.0000946074
AN:
0.0000946074
Gnomad4 NFE
AF:
AC:
0.00235405
AN:
0.00235405
Gnomad4 OTH
AF:
AC:
0.00142315
AN:
0.00142315
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
12
ExAC
AF:
AC:
129
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
FOXC2: BS1, BS2 -
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Distichiasis-lymphedema syndrome Uncertain:1
Apr 03, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Pathogenic
Sift
Uncertain
.;D
Sift4G
Benign
.;T
Polyphen
D;D
Vest4
0.79
MVP
0.85
ClinPred
T
GERP RS
Varity_R
gMVP
Mutation Taster
=28/72
disease causing
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at